Literature DB >> 21267668

Genes and regulatory networks involved in persistence of Mycobacterium tuberculosis.

Xiaozhen Wang1, Honghai Wang, Jianping Xie.   

Abstract

The causative agent of tuberculosis, Mycobacterium tuberculosis, is one of the most successful of human pathogens. It can evade the host immune response and establish a persistent infection or enter a dormant state within the host which can be reactivated if the host becomes immuno-compromised. Both of these features are major obstacles to tuberculosis eradication. Dormancy and reactivation of M. tuberculosis are tightly coordinated dynamic processes involving numerous genes and their products. Molecular mechanisms underlying M. tuberculosis persistence may provide an opportunity for the discovery of effective drug targets for tuberculosis control. Here, we review the genes required for M. tuberculosis persistence and propose a regulatory network for the action of these genes using text mining. This should provide fresh insights into the persistence mechanisms of M. tuberculosis and suggest candidates for new drug targets and immune intervention.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21267668     DOI: 10.1007/s11427-011-4134-5

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  9 in total

Review 1.  Latent tuberculosis infection: myths, models, and molecular mechanisms.

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

2.  Ribosomal maturation factor (RimP) is essential for survival of nontuberculous mycobacteria Mycobacterium fortuitum under in vitro acidic stress conditions.

Authors:  Ragothaman M Yennamalli; Gopal S Bisht; Rahul Shrivastava
Journal:  3 Biotech       Date:  2019-03-06       Impact factor: 2.406

3.  A transcriptional dynamic network during Arabidopsis thaliana pollen development.

Authors:  Jigang Wang; Xiaojie Qiu; Yuhua Li; Youping Deng; Tieliu Shi
Journal:  BMC Syst Biol       Date:  2011-12-23

Review 4.  Latent Tuberculosis: Models, Computational Efforts and the Pathogen's Regulatory Mechanisms during Dormancy.

Authors:  Gesham Magombedze; David Dowdy; Nicola Mulder
Journal:  Front Bioeng Biotechnol       Date:  2013-08-27

5.  Combined Systems Approaches Reveal a Multistage Mode of Action of a Marine Antimicrobial Peptide against Pathogenic Escherichia coli and Its Protective Effect against Bacterial Peritonitis and Endotoxemia.

Authors:  Xiumin Wang; Da Teng; Ruoyu Mao; Na Yang; Ya Hao; Jianhua Wang
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

6.  Significant under expression of the DosR regulon in M. tuberculosis complex lineage 6 in sputum.

Authors:  Boatema Ofori-Anyinam; Gregory Dolganov; Tran Van; J Lucian Davis; Nicholas D Walter; Benjamin J Garcia; Marty Voskuil; Kristina Fissette; Maren Diels; Michèle Driesen; Conor J Meehan; Dorothy Yeboah-Manu; Mireia Coscolla; Sebastien Gagneux; Martin Antonio; Gary Schoolnik; Florian Gehre; Bouke C de Jong
Journal:  Tuberculosis (Edinb)       Date:  2017-03-04       Impact factor: 3.131

7.  Site-specific His/Asp phosphoproteomic analysis of prokaryotes reveals putative targets for drug resistance.

Authors:  Shu-Jung Lai; I-Fan Tu; Wan-Ling Wu; Jhih-Tian Yang; Louis Y P Luk; Mei-Chin Lai; Yu-Hsuan Tsai; Shih-Hsiung Wu
Journal:  BMC Microbiol       Date:  2017-05-25       Impact factor: 3.605

8.  Impact of the Polymorphism of the PACRG and CD80 Genes on the Development of the Different Stages of Tuberculosis Infection.

Authors:  Elena Yu Bragina; Nadezhda P Babushkina; Anna F Garaeva; Alexey A Rudko; Dmitry Yu Tsitrikov; Densema E Gomboeva; Maxim B Freidin
Journal:  Iran J Med Sci       Date:  2019-05

9.  Truncation of C-Terminal Intrinsically Disordered Region of Mycobacterial Rv1915 Facilitates Production of "Difficult-to-Purify" Recombinant Drug Target.

Authors:  Monika Antil; Sébastien G Gouin; Vibha Gupta
Journal:  Front Bioeng Biotechnol       Date:  2020-05-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.